Long-duration effect and the postsynaptic compartment: study using a dopamine agonist with a short half-life

Area of Science:

• Neuroscience
• Pharmacology
• Neurology

Background:

• Levodopa offers sustained motor benefits in Parkinson's disease (PD), potentially due to its long action.
• This effect may stem from presynaptic storage or postsynaptic adaptations.
• Previous research showed ropinirole, a dopamine agonist, also induces a long-duration response (LDR) in PD patients.

Purpose of the Study:

• To investigate the motor response to lisuride, a short half-life dopamine agonist, in levodopa-naive PD patients.
• To determine if lisuride induces an LDR, similar to levodopa and ropinirole.

Main Methods:

• Levodopa-naive PD patients received lisuride until maximum effect.
• Lisuride was then randomly switched to placebo in a blinded manner.
• Motor function was assessed using the Unified Parkinson's Disease Rating Scale (UPDRS) and specific motor tests.

Main Results:

• Switching from lisuride to placebo resulted in a decline of UPDRS motor scores and test performance to baseline levels.
• This decline occurred within an average of 9.0 +/- 1.9 days.
• The findings indicate a sustained effect of lisuride despite its short half-life.

Conclusions:

• The short-acting dopamine agonist lisuride induces a long-duration response in Parkinson's disease patients.
• This LDR phenomenon, observed with lisuride, ropinirole, and levodopa, suggests a common mechanism.
• The sustained motor benefit is likely mediated by postsynaptic pharmacodynamic changes rather than presynaptic storage.